Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy
International Journal of Molecular Sciences · 20.07.2025 · 26 (14) · 6973
DOI: 10.3390/ijms26146973 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2025. Verfasst von Aekkhaluck Intharuksa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Genistein, Isoflavones, Phytoestrogens, Hormone Replacement Therapy. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of Research Administration, Chiang Mai University.
Abstract (Originalsprache)
Menopause is characterized by a decline in estrogen levels, leading to symptoms such as vasomotor instability, osteoporosis, and increased cardiovascular and cognitive risk. Hormone replacement therapy (HRT) remains the gold standard for managing menopausal symptoms; however, concerns regarding its long-term safety, including elevated risks of cancer and cardiovascular events, have prompted interest in alternative therapies. Phytoestrogens, particularly the isoflavones daidzein and genistein, are plant-derived compounds structurally similar to 17β-estradiol (E2) and capable of binding estrogen receptors. Found abundantly in soybeans and red clover, these compounds exhibit selective estrogen receptor modulator (SERM)-like activity, favoring ERβ over ERα, which underlies their tissue-specific effects. In vitro, in silico, and in vivo studies demonstrate their ability to modulate estrogenic pathways, inhibit oxidative stress, and influence reproductive and neurological function. Clinical trials show that daidzein and genistein, especially in equol-producing individuals, can reduce vasomotor symptoms such as hot flashes and night sweats. While results across studies vary, consistent findings support their safety and modest efficacy, particularly for women unable or unwilling to use HRT. Pharmacokinetic studies reveal moderate bioavailability and interindividual variability due to gut microbiota metabolism. At dietary levels, these compounds are generally safe, although high-dose supplementation is discouraged in individuals with hormone-sensitive cancers. Emerging evidence suggests lifelong consumption of soy-based foods may reduce cancer risk. In conclusion, daidzein and genistein represent promising, well-tolerated natural alternatives to conventional HRT, offering symptom relief and additional health benefits. Further research is warranted to optimize dosing, improve clinical outcomes, and clarify long-term safety in diverse populations, particularly with genetic variations in isoflavone metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.
- Kanchanabhishek Institute of Medical and Public Health Technology, Faculty of Public Health and Allied Health Science, Praboromarajchanok Institute, Nonthaburi 11150, Thailand.
- Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- College of Public Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
- Center of Excellence on Natural Products for Neuroprotection and Anti-Ageing, Chulalongkorn University, Bangkok 10330, Thailand.
ORCID-Profile: Aekkhaluck Intharuksa, Warunya Arunotayanun, Mingkwan Na Takuathung, Siripat Chaichit, Anchalee Prasansuklab, Buntitabhon Sirichanchuen, Suthunya Chupradit
Förderung
- Office of Research Administration, Chiang Mai University
Zitieren
APA
Intharuksa, A., Arunotayanun, W., Na Takuathung, M., Chaichit, S., Prasansuklab, A., Chaikhong, K., Sirichanchuen, B., Chupradit, S., & Koonrungsesomboon, N. (2025). Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy. International Journal of Molecular Sciences, 26(14), 6973. https://doi.org/10.3390/ijms26146973
Vancouver
Intharuksa A, Arunotayanun W, Na Takuathung M, Chaichit S, Prasansuklab A, Chaikhong K, et al. Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy. International Journal of Molecular Sciences. 2025;26(14):6973. doi:10.3390/ijms26146973
BibTeX
@article{Intharuksa2025,
author = {Intharuksa, Aekkhaluck and Arunotayanun, Warunya and Na Takuathung, Mingkwan and Chaichit, Siripat and Prasansuklab, Anchalee and Chaikhong, Kamonwan and Sirichanchuen, Buntitabhon and Chupradit, Suthunya and Koonrungsesomboon, Nut},
title = {Daidzein and Genistein: Natural Phytoestrogens with Potential Applications in Hormone Replacement Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6973},
doi = {10.3390/ijms26146973}
}
EUVIMED